摘要
目的探讨穴位敷贴治疗小儿哮喘缓解期肺脾气虚证的临床疗效,为临床治疗提供依据。方法选取我院儿科门诊收治的90例哮喘缓解期患儿为研究对象,按2∶1随机分为治疗组60例和对照组30例。治疗组采用穴位敷贴治疗,对照组采用布地奈德气雾剂治疗,2组均以3月为1个疗程,2个疗程后比较2组患儿的临床疗效及缓解期各症状的改善情况。结果治疗组总有效率为83.3%,对照组为73.3%,2组总有效率经统计学分析,差异有统计意义(P<0.05);2组均能减少哮喘发作次数,改善鼻痒、喷嚏,流涕,面色,精神,痰涎,食欲、食量,气短症状(P<0.05),但在减少哮喘发作次数上治疗组优于对照组(P<0.05);治疗组能减少患儿呼吸道感染次数,改善其出汗症状(P<0.05);2组在改善舌象、大便方面效果不明显,治疗前后比较,差异无统计意义(P>0.05)。结论穴位敷贴是防治小儿哮喘缓解期肺脾气虚证简便、有效的方法之一,值得在临床推广应用。
Objective To explore the clinical efficacy of point application therapy in the treatment of children with asthma in remission stage of lung and spleen qi deficiency syndrome.Methods 90 cases of children asthma in remission stage were divided into treatment group with 60 and control group with 30 by 2 ∶ 1 ratio.The treatment group was acupoint sticking.The control group was treated with Budesonide Aerosol.Three months as one course.Compare the clinical efficacy of two groups,as well as the improvement of symptoms in remission period before and after treatment in 2 courses.Results After treatment,the total effective rates of treatment group and control group were 83.3% and 73.3% respectively with statistically significant difference（ P〈0.05）.Two groups could both reduce the number of asthma attack,improve nasal itching and sneezing,runny nose,complexion,spirit,phlegm,appetite,shortness of breath（ P〈0.05）.But reduction of the asthma attacks frequency in treatment group was better than it in control group（ P〈0.05）;the treatment group could reduce the incidence of respiratory infection,improve sweating symptoms（ P〈0.05）;the improvement of the tongue,stool before and after treatment had no difference in two groups（ P〉0.05）.Conclusion Point application therapy is one of the simple and effective methods to prevent children with asthma in remission stage of lung and spleen qi deficiency syndrome,and it is worthy of clinical application and promotion.
出处
《中医儿科杂志》
2016年第6期34-37,共4页
Journal of Pediatrics of Traditional Chinese Medicine
基金
江苏省中医药管理局课题(LZ13184I)
关键词
小儿哮喘
缓解期
肺脾气虚证
穴位敷贴法
临床研究
children with asthma
remission
lung and spleen qi deficiency syndrome
point application therapy
clinical research
